Tirzepatide acts on both GLP-1 and GIP receptors, which increase insulin secretion, slow stomach emptying, decrease appetite, and improve glucose control
Acknowledgments The authors have no acknowledgment to declare
99.276% purity (HPLC) Third-party tested Freedom Diagnostics Identity confirmed Certificate of Analysis Tested by Freedom Diagnostics 03/23/2026 Tested by Janoshik 11/10/2025 Key Ingredients A stable pentadecapeptide (15 amino acids) studied in relation to cytoprotective mechanisms, nitric oxide system interactions, growth factor expression, and angiogenic pathways
The most reported side effects of Semaglutide are gastrointestinal in nature
Closely linked to metabolic syndrome, NAFLD involves intricate pathological mechanisms, including dysregulated lipid metabolism, insulin resistance, oxidative stress, and inflammation [165,166,167]